To ascertain the effect of age on hearing preservation, facial nerve outcome, and complication rates after acoustic neuroma surgery. Study Design: Retrospective chart review. Two study arms were used: a comparison of the authors' oldest patients with their youngest patients (extremes of age arm) and an analysis of all middle fossa surgical procedures (middle fossa arm). Setting: Tertiary referral center Patients: Total of 329 patients. For the extremes of age arm, 205 patients were studied in two cohorts with 150 older patients (>60 years) compared with 55 younger patients (<40 years). The approaches included 21 middle fossa (MF), 38 retrosigmoid (RS), and 91 translabyrinthine (TL) procedures in the older group versus 25 MF, 17 RS, and 13 TL in the younger. For the middle fossa arm, there were 170 patients (age range 15-76 years) who underwent the MF approach for an attempt at hearing preservation. Main Outcome Measures: Hearing preservation was defined as the maintenance of either class A or class B hearing (AAO-HNS class). Good facial nerve outcome was considered the maintenance of either grade 1 or 2 (House-Brackmann scale).
Acoustic neuromas (AN) in young and middle-aged patients are usually treated surgically. The rates of hearing preservation, facial nerve function, and complications after tumor resection in the general population have been well described by multiple retrospective reviews (1) (2) (3) (4) (5) . However, because of perceived increases in surgical risk and shorter expected patient life span, the trend in managing these tumors in patients over 60 years old has been toward nonoperative strategies. Consequently, the literature on AN in the elderly tends to focus more on operative versus nonoperative management (6) (7) (8) (9) (10) (11) . Because the aging baby boomer cohort has improved health and a lengthened life expectancy in comparison with earlier generations (12) (13) (14) , the role of age in the surgical management of AN needs to be evaluated carefully. Functional outcomes are particularly important in this active and vibrant patient population (15) . It is possible, however, that older age may diminish the ability of the cochlear or the facial nerve to tolerate the surgical manipulation necessary to resect an AN. We sought to ascertain the effect of age on hearing preservation, facial nerve outcome, and complication rates after AN surgery.
MATERIALS AND METHODS

Study Design and Patient Population
Our retrospective study of 329 patients included two arms to evaluate for an effect of age on AN surgical outcomes. The first was a comparison of our oldest patients versus our youngest patients (extremes of age study arm). This was because we hypothesized that any major differences in surgical outcomes based on age would be most easily detectable using patients at the extremes of age. The second was an analysis of all middle fossa surgery outcomes (middle fossa arm). This study arm was used to evaluate for subtle effects of age on hearing and facial nerve outcomes, because the middle fossa route is our usual approach for hearing conservation surgery.
The extremes of age study arm was a retrospective study comparing older and younger patients (total n ‫ס‬ 205). All patients over 60 years of age who underwent surgical excision of an AN were compared with those patients under than 40 years of age. The details of the two groups of patients are given in Table 1 . The expected patient life span was determined from an actuarial table (16) . Tumor size was measured as millimeters in the cerebellopontine angle (CPA). Tumors wholly confined to the internal auditory canal were categorized as intracanalicular (0 mm).
The average tumor size in the patients undergoing the middle fossa approach was much smaller than that in the patients undergoing the retrosigmoid approach. This reflects our philosophy of using the middle fossa approach as our primary strategy toward hearing preservation, while reserving the retrosigmoid approach only for hearing conservation attempts for tumors measuring 15 to 25 mm in the CPA (17) . Older patients undergoing the translabyrinthine approach also tended to have larger tumors, because our usual policy for older patients with small tumors and poor hearing is to either monitor them with serial magnetic resonance imaging or treat them with stereotactic radiotherapy.
The middle fossa study arm was a retrospective review of all patients who underwent the middle fossa approach for resection of an AN, regardless of age. This included patients at the age extremes as well as those 40 to 60 years old (total n ‫ס‬ 170, Table 1 ). This larger patient population permitted us to study the effect of patient age on hearing preservation with greater power than did the extremes of age study arm. The average patient age was 45 ± 10 years (mean ± SD), and the average tumor size was 5 ± 6 mm (mean ± SD) in the CPA.
Main Outcome Measures
Good hearing preservation was defined as postoperative AAO-HNS class A or B hearing (18) . We did not include patients in this analysis who had class C or D hearing preoperatively. We measured postoperative hearing at least 3 months after surgery. Good postoperative facial function was considered House-Brackmann grade 1 or 2 (19) . We did not include patients in this analysis who had grade 3 or worse facial function preoperatively. Postoperative facial weakness was not tabulated unless it was present 1 year after surgery.
Postoperative complications were also tabulated. Cerebrospinal fluid (CSF) leaks were identified separately from other complications. This included all postoperative leaks identified, whether they required lumbar subarachnoid drain and/or reoperation. Fewer than 5% of patients with leaks required operative intervention (20) .
Statistical Analysis
SPSS (version 10.0; SPSS, Inc., Chicago) was used for statistical analysis. All averages are reported as mean ± standard deviation. We used the two-tailed t test to compare continuous variables (patient age and tumor size). Multiple logistic regression analysis was performed to account for confounding variables in the comparison of discrete variables (hearing preservation, good facial function, CSF leak, other complications). This technique was also used for the continuous variables to verify the t test results. A stepwise entry methodology was used. For all analyses, statistical significance was determined if p Ն 0.05.
RESULTS
Extremes of Age Study Arm
This first arm was designed to compare patients at the extremes of age for each of the three surgical approaches to identify major differences that might be associated with patient age. The main outcome measures are presented in Table 2 . The rate of hearing preservation was lower in the older patient group than in the younger patient group for both the middle fossa (29% vs. 60%) and the retrosigmoid (8% vs. 15%) approaches. Multiple logistic regression analysis was performed to identify an effect of age on hearing preservation, while accounting for surgical approach and tumor size. This demonstrated that patients older than 60 years were less likely to have All values are mean ± standard deviation. The range is in brackets. Expected lifespan was calculated from actuarial data (25) . 
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preserved good hearing than those younger than 40 years (p ‫ס‬ 0.048, odds ratio ‫ס‬ 0.30).
The rate of good postoperative facial function did not seem to be dramatically different between the older and the younger age groups for any of the surgical approaches (87-100%). Multiple logistic regression analysis accounting for surgical approach and tumor size demonstrated that there was no effect of age grouping on facial outcomes (p ‫ס‬ 0.2). There was a trend toward slightly higher rates of CSF leak (0-15%) in the older patient group (p ‫ס‬ 0.07), but there was no statistically significant difference in the rate of other complications (0-7%, p ‫ס‬ 0.8) between the age extremes.
Middle Fossa Study Arm
This second arm was a review of all patients who underwent the middle fossa approach. It was designed to identify subtle associations of age with hearing and facial nerve outcomes in our primary hearing preservation approach. First, we compared the average patient age and tumor size for patients in whom we were and were not able to preserve hearing and maintain good facial nerve function (Fig. 1.) . Patients in whom hearing was preserved were younger than those in whom hearing was not preserved (A, preserved: 48 ± 11 years, n ‫ס‬ 75 vs. not preserved: 52 ± 9 years, n ‫ס‬ 88, p ‫ס‬ 0.01). Additionally, there was a trend toward patients with a smaller tumor size having an improved rate of hearing preservation (B, preserved: 4 ± 5 mm, n ‫ס‬ 74 vs. not preserved: 6 ± 6 mm, n ‫ס‬ 88, p ‫ס‬ 0.08). Neither younger patient age (C, good facial function: 50 ± 10 years, n ‫ס‬ 155 vs. poor facial function: 51 ± 7 years, n ‫ס‬ 10, p ‫ס‬ 0.8) nor tumor size (D, good facial function: 5 ± 6 mm, n ‫ס‬ 154 vs. poor facial function: 6 ± 5 mm, n ‫ס‬ 10, p ‫ס‬ 0.7) were correlated with good facial function.
Because larger tumor size can be associated with lower hearing preservation rates and worse facial nerve outcomes, it is important to distinguish between the effects of patient age and the effects of tumor size. Multiple logistic regression analysis was then performed to account for tumor size as a confounding variable. This revealed that older age was associated with poorer rates of hearing preservation (p ‫ס‬ 0.01; odds ratio ‫ס‬ 1.044). This means that the odds of hearing preservation decreases by 4.4% per year. However, older age was not an independent predictor of poor facial function (p ‫ס‬ 0.7).
DISCUSSION
Both arms of the study demonstrate that older patients have a decreased rate of hearing preservation when tumor size was controlled for. Additionally, there was also a trend toward higher CSF leak rates in older patients, but there was no statistically significant effect of age on other complications or facial nerve function. However, our facial function results may be biased toward better preservation rates in older patients because we typically are less aggressive in trying to achieve total tumor removal in this population. We may leave a small bit of tumor on the facial nerve to reduce trauma and subsequent morbidity. A near-total resection means leaving a scrap of tumor no larger than 25 mm 2 (5 × 5 mm) and 2 mm thick, and a subtotal resection means leaving any larger piece. It is likely that without our altered surgical technique for older patients, there would have been a significantly reduced rate of good postoperative facial The number of patients in each category may be less than the total number of patients studied. Only patients with preoperative AAO-HNS class A or B hearing or preoperative House-Brackmann grade 1 or 2 facial function were included in the analysis. a This middle age group of patients was not use for the extremes of age study arm, but was included in the middle fossa study arm. CSF, cerebrospinal fluid; n/a, not applicable.
EFFECT OF AGE ON ACOUSTIC NEUROMA OUTCOMES
function (as there was with the rate of hearing preservation). We did not have enough patients to perform a quantitative analysis of the effect of the completeness of surgical resection on hearing and facial nerve function.
Our hearing and facial nerve preservation findings concur with and expand on those of other investigators. Brackmann et al. (3) found that the average age of patients who lost hearing postoperatively with the middle fossa approach was slightly higher than in patients who did not, although the difference was not significant. Ramsay and Luxford (6) found similar postoperative facial nerve function in patients older than 70 years and younger than 70 years of age, all of whom were treated with the translabyrinthine approach.
Certainly, there is a generalized increased risk of surgical complications in older patients in all types of surgery. This is predominantly due to the steady decline in organ system functioning during aging (21) . One might reasonably suspect that complications during AN surgery should occur more frequently in older patients. However, older patient age has not been shown to be associated with increased complications in AN surgery (22, 23) . Our data support these studies, in that we saw no effect of older age on complication rates. The middle fossa approach is thought to be more technically challenging in older patients because of thinning and adhesions of the dura. Indeed, patient age greater than 60 years has been suggested as a relative contraindication to the middle fossa approach (24, 25) . Our philosophy has been to base our surgical approach on tumor size, location, and residual hearing, and we do not believe that older patient age is a contraindication to the middle fossa approach. Meticulous surgical technique in raising the craniectomy bone flap, suture repair of any dural tears, and careful bipolar cautery of any bleeding vessels is critical to the successful prevention of technical complications. Also larger tumor size is probably not associated with an increased rate of CSF leak (20) .
The dilemma in treating older patients is whether to remove a small AN to preserve potential hearing loss in the years to come. Our philosophy on the management of AN in patients older than 60 years is to treat with either surgery or stereotactic radiation only if the patient has a large tumor with substantial brainstem compression, has progressive worsening of symptoms (particularly failing balance), or demonstrates tumor growth at a rate that will eventually lead to serious brainstem compression within the patient's predicted life span. By far the majority of older patients with tumors smaller than 2 cm in the CPA undergo a period of observation with serial magnetic resonance imaging to determine tumor growth rate, before intervention strategies are decided on. The risk of tumor progression and hearing loss (with either no treatment or stereotactic radiation) and the risk of the development of a radiation-induced malignancy (with stereotactic radiation) during an expected life span of 15 to 20 years should be weighed against the risks and benefits of tumor removal in consultation with the patient.
FIG. 1.
The effect of patient age and tumor size on surgical outcomes with the middle fossa approach. Patients in whom hearing (A, B) or good facial nerve function (C, D) were able to be preserved were compared with those in whom they could not be preserved. The box and whisker plots demonstrate the 25th and 75th percentiles of the samples (bottom and top of the boxes), the medians (line in the middle of the boxes), and the extent of the sample (whiskers above and below the boxes). Outliers more than 1.5 times the interquartile range away from the top or bottom of the box are identified (o). Younger patient age (A, 48 ± 11 years, n = 75, vs. 52 ± 9 years, n = 88, p = 0.01) was correlated with hearing preservation. There was a trend toward hearing preservation in patients with smaller tumors (B, 4 ± 5 mm, n = 74, vs. 6 ± 6 mm, n = 88, p = 0.08). The number of patients is less than the total number of patients studied because only patients with preoperative AAO-HNS class A or B hearing were analyzed. Neither younger patient age (C, 50 ± 10 years, n = 155, vs. 51 ± 7 years, n = 10, p = 0.8) nor tumor size (D, 5 ± 6 mm, n = 154, vs. 6 ± 5 mm, n = 10, p = 0.7) was correlated with good facial function.
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The fate of the tumor remnant after less-than-complete acoustic neuroma resection 
RESULTS:
Fifty-two patients were included in the study group. Recurrences were seen in 1 (3%) of 33 patients who had a near-total resection compared with 6 (32%) of 19 patients who had a subtotal resection. After adjustment for follow-up time and large tumor size, the odds ratio for recurrence was 12 times larger for subtotal than for near-total resections (P ‫؍‬ 0.033). All recurrences were seen following the translabyrinthine approach in the midcerebellopontine angle. None were encountered in the internal auditory canal. The mean time interval from surgery to the detection of a recurrence was 3 years (range, 1 to 5 years).
CONCLUSIONS:
The recurrence rate when performing a near-total resection is low but is substantially higher with a subtotal resection. Recurrences can be detected within the first 5 postoperative years. We recommend near-total resection in any patient if needed to preserve neural integrity. Subtotal resection is best avoided whenever possible; however, adjunctive treatment with stereotactic radiotherapy may be considered. The goals of acoustic neuroma (AN) surgery are tumor control and preservation of cranial nerves, including the facial nerve and at times the auditory nerve. Balancing the priority of these goals is influenced by other considerations such as patient age and life expectancy, overall health and comorbidities, and tumor adherence and size. Microsurgical gross total tumor removal is by far the most common result of AN surgery. Less-than-complete resection most commonly involves an intraoperative decision to leave tumor remnants behind as a concession to neural integrity. Elderly or debilitated patients may have a subtotal removal planned preoperatively to minimize the morbidity and mortality associated with a more extensive and lengthy procedure. The aim of the present study was to determine the risk of tumor recurrence with incomplete AN resection.
METHODS
Seventy-nine patients with incomplete AN resections from 1978 to 1999 were identified, accounting for less than 10% of the patients who underwent AN surgery at our institution. At the University of California-San Francisco (UCSF), a team composed of a neurotologist and a neurosurgeon perform the procedure. A retrospective chart review was performed from records kept by both departments and entered into a computerized database. The study protocol was approved by the UCSF Committee on Human Research.
Clinical parameters, including patient age, gender, symptoms, surgical approach, and postopera-tive complications, were recorded. Tumor size, based on the greatest dimension within the cerebellopontine angle (CPA), was obtained from preoperative imaging data. The surgeons' notes were examined to ascertain the indication for performing an incomplete resection whenever possible. As opposed to defining residual tumor as a percentage of the original tumor, near-total resections were defined by tumor remnants no greater than 25 mm 2 and 2 mm thick; subtotal resections included anything larger 1 (Fig 1) . Facial nerve outcomes with a minimum of 1-year follow-up were recorded, based on the House-Brackmann (HB) grading system.
Our routine protocol for postoperative tumor surveillance consists of imaging at 1 and 3 years for tumors that have been totally removed. Incompletely resected tumors are followed annually with a gradual lengthening of the time between scans when there is no evidence of recurrence. Because UCSF is a tertiary referral center, some patients receiving longitudinal follow-up care at other institutions had different imaging regimens. The modality most com- monly used was magnetic resonance imaging (MRI), although a few patients early in the study period had computed tomography (CT). All patients, except for 1, had an MRI study at some point in their follow-up. The results of all postoperative follow-up imaging were recorded to identify residual and/or recurrent tumor. No tumor recurrence was defined by the absence of visible tumor on imaging after a minimum follow-up of 3 years or if stable residual tumor was present. Stable residual tumor was defined as a tumor remnant that remained unchanged on serial imaging. Recurrent tumor was defined as tumor growth on serial imaging. Additionally, tumor recurrence was defined as when the patient underwent additional treatment (either stereotactic radiation or repeat surgery) after only a single scan because of the large tumor size.
Statistical Analysis
Stata (version 7.0; Stata Corp, College Station, TX), SPSS (version 10.0; SPSS, Inc, Chicago, IL), and StatXact (version 3.0; Cytel Software, Cambridge, MA) were used for statistical analysis. Fisher exact test and 2-sided t test were used to evaluate bivariate relationships. Logistic regression was performed on recurrence and good facial nerve function (HB I or II) to assess the influence of subtotal versus near-total resection, age, large tumor size (Ն25 mm), and other predictors. Odds ratios were calculated and statistical significance was determined if P Ͻ 0.05. Logistic regression was followed by statistical analyses using exact stratified contingency table analysis to check the stability of the logistic regression results.
RESULTS
Patient Population
There were 50 patients (63%) with near-total resections and 29 patients (37%) with subtotal resections (Table 1 ). The mean age was 59 years (range, 21 to 81 years). Patients who underwent subtotal resections tended to be older than the near-total group (mean, 62 versus 57 years; P ϭ 0.10). The mean tumor size was significantly greater in the subtotal resection group than in the near-total resection group (31 mm versus 24 mm, P ϭ 0.005). The predominant approach used in this group of patients was the translabyrinthine (TL), accounting for 72% of the operations. The average tumor size was greatest for the TL approach (26 mm) followed by the retrosigmoid (RS) (22 mm) and the middle fossa (MF) (7 mm) approaches. A comparison between the near-total and subtotal groups showed no significant difference in terms of gender, approach, and follow-up period. Postoperative complications are presented in Table 2 . The cerebellar peduncular infarcts were areas of distal anterior inferior cerebellar artery ischemia (with minimal symptomatology), not major strokes. 2 There were no known tumorrelated deaths, but there were 4 unrelated deaths seen on long-term follow-up.
Indications for Incomplete Resection
Although all patients had an incomplete resection to preserve facial nerve integrity, there were additional indications for this technique in a few patients. One patient had a near-total resection after experiencing bradyarrhythmias during dissection of the tumor from the brain stem. Four patients had planned incomplete resections for other reasons, including advanced age and medical comorbidities. Finally, 4 patients had subtotal resections after initial treatment with stereotactic radiotherapy failed. Of these, 3 patients had a ventriculoperitoneal shunt placed preoperatively to treat hydrocephalus and subsequently underwent a planned subtotal resection for brain stem decompression. The time interval between failed radiotherapy and operative intervention was from 3 to 17 months. Three of 4 of these patients had no evidence of recurrence at 3 years (the fourth patient was lost to follow-up).
Facial Nerve Outcomes
Good facial nerve function at 1 year postoperatively, defined as HB grade I or II, was seen in 57 (81%) of the 65 patients (Table 3 ). There were no detectable associations between good facial nerve function and tumor size (P ϭ 0.98), age (P ϭ 0.41), or approach (P ϭ 0.66). Logistic regression analysis demonstrated no statistically significant difference in good facial nerve function between the near-total and subtotal groups when controlling for age, tumor size, and operative approach (P Ͼ 0.1).
Radiographic Imaging
Sixty-four patients had imaging available for at least 1 year postoperatively, with a mean radiographic follow-up period of 4.3 years (range, 1 to 13 years). Imaging revealed the residual tumor in approximately 20% of patients in the near-total group and 80% of patients in the subtotal group (Figs 2 and 3 ). The proportion of scans at each year that revealed tumor remained relatively stable over the study period.
Recurrence Risk
The risk of developing a tumor recurrence was determined in a subgroup of 52 patients who met the criteria for adequate follow-up, as described in Methods. The mean follow-up time for these patients was 5 years (maximum, 13 years). Recurrences were seen in 1 (3%) of 33 patients who had a near-total resection compared with 6 (32%) of 19 patients who had a subtotal resection. Multiple logistic regression analysis was then performed to adjust for differences in follow-up time and large tumor size (Ն25 mm). From this analysis, the odds ratio for recurrence was found to be 12 times larger for subtotal than for near-total resections (P ϭ 0.033) (Fig 4) .
Seven patients had recurrent tumors (Table 4 ). All recurrences were seen following the TL approach (Fig 5) . The locations of the recurrences were in the mid-CPA, and none were encountered in the internal auditory canal. The recurrent tumors were all large at the initial operation (mean, 37 mm; P ϭ 0.001); however, large size as a risk factor for recurrence was not significant when controlling for subtotal resections (P ϭ 0.32). There was no association between patient age and recurrence risk (P ϭ 0.19). The mean time interval from surgery to the detection of a recurrence was 3 years (range, 1 to 5 years). Stereotactic radiation treatment was recommended in 5 patients. The remaining 2 patients underwent a repeat incomplete resection with the RS approach (1 NT and 1 ST).
DISCUSSION
The rationale for using an incomplete tumor dissection technique is dictated by the risk/benefit ratio for the patient. Our data suggest that the risk of tumor recurrence after a near-total resection is quite low. Although we did not perform a randomized controlled trial to determine the degree of improvement in facial nerve outcomes, it seems logical to conclude that any further tumor removal would have compromised facial nerve function. Every patient in our study was selected because of a particularly high level of tumor adherence. Comparisons with stratified control patients who underwent a complete tumor resection would be inherently flawed, because these patients did not have tumors that were as difficult to dissect. In our experience, substantial adherence of the tumor to the facial nerve has a high risk of a poor facial nerve outcome. Near-total resection involves leaving a small rind of tumor to better preserve the facial nerve. Incomplete resection is helpful in preserving facial nerve integrity because as the tumor enlarges, it compresses the facial nerve and the tumor-arachnoid mater plane is lost.
3 Difficulty in identifying a plane between the tumor and the facial nerve most commonly occurred just medial to the porus acousticus (Fig 1) . The facial nerve, which follows the shape of the tumor, often becomes splayed and thinned in this region, possibly accounting for the adherence.
Subtotal resection, in contrast, leads to a 12-time higher risk of recurrence. This may be explained merely by the larger initial tumor size in the subtotal group compared with the neartotal group (P ϭ 0.005), resulting in a more tenuous and adherent facial nerve. However, another explanation may be distinct variations in AN biological behavior. Although most tumors are slow growing (approximately 2 mm per year), 3, 4 a small subset demonstrate rapid growth. 5 One patient illustrating an aggressive variant had a subtotal resection for a 25-mm tumor. She subsequently had 2 large symptomatic cystic recurrences after a 2-to 3-year interval. We use the subtotal resection technique with large tumors that have a large area of tumor stuck to the facial nerve and/or brain stem or to minimize other complications, particularly in elderly or debilitated patients. Rarely, an intraoperative event is the indication for a subtotal resection. 3 We favor a conservative approach OtolaryngologyHead and Neck Surgeryand often use the subtotal technique to treat patients for whom stereotactic radiation has failed. This is done to minimize the attendant risks engendered from radiation-induced changes. Microsurgery is often difficult due to inflammation and fibrosis that interfere with the identification of normal dissection planes, leading to poorer facial nerve outcomes. Recurrence rates of near-total versus subtotal residuals (n ϭ 52). Recurrence was determined by documented growth or recommended treatment. No recurrence was defined by tumor that was stable on serial scans or not visible for a minimum of 3 years. The mean follow-up time was 5 years. There was a substantially higher risk of developing a recurrence if a subtotal resection (32%) was performed compared with a near-total resection (3%) (odds ratio, 12; P ϭ 0.033; details of multiple logistic regression analysis given in text).
OtolaryngologyHead and Neck Surgery
However, we have a particular concern about performing a subtotal resection in tumors with large cystic components. The cyst should not simply be marsupialized; the wall needs to be carefully microdissected from the surrounding normal structures and removed. A tendency exists for the residual cyst wall to reseal. Brain stem compression may result from the cyst recurrence even though the solid (neoplastic) residual has not grown. Stereotactic radiosurgery is not very effective in such cystic recurrences because it is not caused by rapid cell division. It is possible that radiosurgery may even stimulate further cyst expansion in such patients. Thus, a cystic recurrence likely necessitates reoperation.
ANs do not have true capsules. The histopathology includes compressed neoplastic cells at the margin of the tumor surrounded by connective tissue only a few micrometers in thickness. 7 The entire mass contains viable tumor cells that carry the potential for recurrence. Thus, "complete resection leaving only a small amount of capsule" is 
Fig 5. (A)
Near-total recurrence (arrow) seen on MRI 8 years after a TL resection. The tumor recurrence was detected on a 3-year scan and has continued to grow asymptomatically from 3 mm to 18 mm at 8 years after surgery (first patient, Table 4 ). (B) Subtotal recurrence (arrow) in the mid-CPA seen on MRI 3 years after a TL resection (sixth patient, Table 4 ).
OtolaryngologyHead and Neck Surgeryreally incomplete tumor removal. Based on the volume of tumor and "capsule" remaining, it is best defined as a near-total or subtotal removal. Every effort should be made to remove as much of the tumor as possible while only leaving a small rind at areas with difficult planes of dissection. Limiting the gross volume of residual tumor has been shown to improve outcome. 8 One of the pitfalls in performing an incomplete resection occurs with the RS approach when tumors are truncated at the internal auditory canal without drilling out the intracanalicular component. We do not recommend this technique because these extensive residuals carry a high risk of recurrence. Indeed, even the need to perform a "blind sweep" of the fundus after a proper internal auditory canal drillout with the RS approach carries a higher incidence of tumor recurrence. 9 In contrast, all of the recurrences in our study were centered in the CPA and followed a TL resection. Because the majority of the near-total remnants and some of the subtotal remnants remained undetectable on serial follow-up imaging, we suspect that there was postoperative tumor regression. Other plausible explanations include tumor necrosis, detection limitations of the MRI, or an interruption of the blood supply preventing contrast enhancement. Residual remnants have been shown to be relatively avascular in a study looking at tumors managed with staged procedures. 3 Nonetheless, the bipolar electrocautery should be used to coagulate the remnant to cause further devascularization. The location of remnant appears to influence the recurrence risk. The blood supply of the internal auditory canal and brain stem may lead to an increased propensity for recurrence in these locations compared with remnants along the facial nerve in the mid-CPA that have a poor vascular supply.
The mean time interval between surgery and tumor recurrence was 3 years (range, 1 to 5 years). All recurrences were seen on either the initial postoperative scan or serial scans that demonstrated growth. No patients had a clinical recurrence after an established quiescent period. This is contrasted by a study that revealed tumor growth in 17 patients after a median of 3.6 years with no evidence of tumor growth. 8 These conflicting observations may be explained by the use of lowersensitivity CT scanning for follow-up in the other study. Consistent with our findings was that once growth was identified, it continued unabated until institution of treatment. 8 AN recurrences are often asymptomatic due to the typical postoperative sequelae of hearing loss and vestibular ablation. It is imperative to follow these patients diligently with other diagnostic modalities that permit early detection and intervention before the need for urgent decompression surgery. The pre-and post-gadolinium enhanced T1-weighted MRI with fat saturation is the imaging of choice due to signal characteristics that allow the differentiation of postoperative scarring, blood, and fat graft from tumor. 10 Treatment options for a recurrent tumor include stereotactic radiosurgery or reoperation typically done via a different approach. In this series, all recurrences followed TL removals, presumably because this is the method typically used for tumors in the size range where less-than-complete removal is most likely to be chosen. When a reoperation is needed following the TL approach, we choose the RS method to avoid having to dissect the fat graft off of the facial nerve. Similarly, we use the TL approach to manage recurrences after other surgeons have left tumor (particularly in the internal auditory canal) during an RS approach to avoid the region of surgical scarring.
CONCLUSION
There has been an evolution in the management of ANs reflecting advances made in medical technology and an improved understanding of the natural progression of the disease. Historically, the goal of complete tumor removal took precedence over other considerations. Patients often presented with advanced disease, leading to unacceptable death rates. Today, high-quality imaging often leads to the diagnosis in patients with less severe symptoms and smaller tumors. A therapeutic dilemma arises when balancing the risk and benefits of a complete versus a less-than-complete resection of a benign tumor. Near-total resection has a low risk of recurrence and may be used in any patient as a concession to neural integrity. There is a substantially higher risk of recurrence with subtotal resections. Meticulous attention is needed to thin the tumor remnant as much as possible, limit it to the CPA, and coagulate it with the electrocautery. The postoperative management should include vigilant surveillance with serial MRI to detect early recurrence. Detection of recurrent tumors was evident relatively early within the first 5 years after surgery.
Is It Worthwhile to Attempt Hearing Preservation in
Larger Acoustic Neuromas? Conclusions: Surgeon and patient alike would always choose a hearing preservation technique if there was no potential for increased morbidity in making the attempt. When compared with the non-hearing preservation translabyrinthine approach, the retrosigmoid approach had a higher incidence of persistent headache. In addition, efforts to conserve the auditory nerve prolong operating time, increase the incidence of postoperative vestibular dysfunction, and carry a slightly higher risk of tumor recurrence. Nevertheless, even though the probability of success is disappointingly small, when excellent hearing is present we favor offering the option of a hearing conservation attempt when the patient has been well informed of the pros and cons of the endeavor. The three principal surgical approaches for acoustic neuroma (AN) removal are the translabyrinthine (TL), retrosigmoid (RS), and middle fossa (MF) approach. Only the latter two approaches provide the possibility of hearing preservation. The results of hearing preservation surgery have been shown to be superior for small tumors when the MF approach is used (1). However, the MF approach is only practicable in tumors with a limited cerebellopontine angle (CPA) extension. This leaves the RS approach as the only alternative when attempting to preserve hearing in larger ANs. Because tumor size is the most important variable influencing hearing outcome, the question arises as to whether hearing preservation surgery should still be attempted via the RS approach in patients with large tumors but serviceable hearing (2-5).
Tumor size itself should not be a criterion in choosing between the RS and TL approach, because both approaches provide adequate exposure, but the potential higher morbidity associated with the RS approach does need to be taken into account. This study was undertaken to determine the rate of hearing preservation in patients with ANs that have a substantial CPA component (Ն 15 mm) so that patients can be appropriately counseled before choosing between a RS and TL approach.
PATIENT POPULATION
This study is a retrospective review of the medical records of patients who have had surgical removal of a histologically confirmed AN in a single tertiary referral center between the years 1984 and 2001. Selection criteria for inclusion in the study were tumor removal via the RS approach, Ն15 mm CPA component, and preoperative hearing of class A or B. Because not every patient with a Ն15 mm AN and preoperative hearing of class A or B was operated on via the RS approach in the institutional series, some selection bias may be present. Several otherwise qualified patients underwent TL removal, especially when adverse predictors, such as deep penetration of the fundus of the internal acoustic canal (IAC) or wide erosion of the porus acousticus, were present. These criteria would have been analyzed in the present study were the data available in our medical records more complete. Arbitrary patient preference was also sometimes a factor in the choice of operative approach.
Hearing class was documented as recommended by the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) (6) . Tumor size was defined as the largest diameter of the CPA portion of the tumor measured from axial magnetic resonance imaging (MRI) scan or axial computerized tomography (CT) scan if MRI was not available. The patients were divided into the following four groups according to tumor size: 15 to 19 mm, 20 to 24 mm, 25 to 29 mm, and Ն30 mm. The pure tone thresholds at 0.5, 1, 2, and 3 kHz (4 kHz was used when 3kHz was not recorded) were averaged, and this pure tone average (PTA) was used along with the best speech discrimination score (SDS) to determine hearing class according to the nomogram provided in the AAO-HNS guidelines. SDS is reported at sensation levels of up to 40 dB or maximum comfortable loudness, whichever is less. This system was used to classify both preoperative and postoperative hearing results.
Several other parameters were recorded at the time of data collection, including age, sex, side of tumor, extent of tumor resection, and facial nerve function. The extent of tumor resection was categorized as total, near total (indicating a small area of tumor capsule no more than 2 mm thick and 5 mm in diameter was left to protect a splayed and adherent facial nerve), or subtotal (indicating a larger remnant of tumor). Postoperative facial nerve outcome was reported according to the HouseBrackmann grading system (7).
Statistical analysis was performed in SPSS program for Windows (Release 7.5, 1996), and statistical significance was set at p < 0.05. Each tumor-size category was compared with the others in paired comparisons. Age, preoperative PTA and SDS, and postoperative PTA and SDS were compared using MannWhitney U test. Intergroup comparison of preoperative and postoperative hearing class was made using Pearson's 2 test. To compare our results with those of other centers performing AN surgery, a review of the literature was performed. A literature search was performed on MEDLINE using the keywords acoustic neuroma, hearing preservation, and retrosigmoid approach. If more than one series had been published by a single center, the most recent results were reviewed.
Approval for the study design was obtained from the University of California, San Francisco Committee on Human Research.
RESULTS
Sixty-four patients with unilateral AN met the inclusion criteria, only one of whom had to be excluded because of inadequate follow-up. The series included 39 female and 24 male patients. The tumor was left-sided in 38 cases and right-sided in 25 cases. We suspect these two numerical asymmetries to have occurred by chance. Total tumor resection was achieved in 49 cases, and near total removal in 14 cases. No tumors were subtotally removed. The mean age of the patients was 45 years (range, 17 to 70). The facial nerve outcomes at 1 year were as follows: grade 1 or 2 ‫ס‬ 54 (86%), grade 3 or 4 ‫ס‬ 6 (10%), and grade 5 or 6 ‫ס‬ 3 (5%).
Postoperative hearing was compared with preoperative hearing for each tumor size group (Table 1) . Good hearing (class A or B) was preserved in only 6.3% (4 of 63) of patients. All of the successes in hearing conservation came in the smaller size groups. No patient with a tumor Ն25 mm in CPA diameter retained hearing in this study. The most favorable results were obtained in the smallest (15 to 19 mm) size group, in which 17.6% (3 of 17) retained good hearing.
No statistical significance was observed between any of the tumor size groups when comparing age and preoperative SDS. The preoperative PTA in the Ն30 mm group was significantly better than in the 15-to 19-mm group (p ‫ס‬ 0.043). The postoperative PTA in the 15-to 19-mm group was significantly better than in the 20-to 24-mm group (p ‫ס‬ 0.042), the 25-to 29-mm group (p ‫ס‬ 0.024), and the Ն30-mm group (p ‫ס‬ 0.031). The postoperative SDS was significantly better in the 15-to 19-mm group than in the 25-to 29-mm group (p ‫ס‬ 0.044), but no significant difference was observed in other group comparisons. When comparisons were made for preoperative hearing class between groups, no statistically significant difference was observed. There was also no difference observed when hearing preservation rates (i.e., numbers of postoperative class A or B results) were compared across groups.
DISCUSSION
The aim of AN surgery is tumor removal with minimal associated morbidity. The rate of functional preservation of the cochlear nerve has increased with the development of modern microsurgical techniques and intraoperative nerve monitoring. Hearing conservation is possible, in certain cases, using either the MF or RS approach. For tumors with limited extension into the CPA, the MF approach has become the method of choice in several major centers. A recent study carried out in our department has demonstrated that more than 60% of tumors with less than 10 mm of CPA extension operated on by the MF approach will retain functional hearing (class A or B), and approximately 95% of these patients will In an earlier study, a comparative analysis between the MF and RS approaches for small ANs (<10 mm CPA component) revealed markedly greater success for the MF approach in these small tumors (1). Compared with our results using the MF approach (for smaller tumors), hearing preservation rates after RS procedures can only be described as disappointing. In the present study, good hearing (A or B) was retained in only 10% of tumors measuring 15 to 24 mm and in no tumors with Ն25 mm in the CPA.
A review of the literature identified a total of 21 studies that contained data on a significant number of tumors of Ն15 mm and focused on hearing preservation surgery by the RS approach (2,4,9-27). Unfortunately, many of these studies provide insufficient data to undertake an analysis stratified by tumor according to the AAO-HNS hearing classification. Among those that do, some adhere to the AAO-HNS guidelines by reporting tumor size in the CPA (Table 2) , whereas others report size of the entire tumor, including the IAC portion (Table 3) (2,9,13-15,22-24,26). The latter method may overestimate tumor size by as much as 10 mm. The data from one study is presented by virtue of its large patient population despite its use of noncomparable measures for both hearing and tumor size (Table 4) (24) . An important limitation of this particular study was that SDSs were only available in 76% of cases preoperatively and in only 50% of patients with some hearing postoperatively.
All of the studies demonstrated decreasing success in hearing preservation with larger tumor sizes. Among those studies reporting CPA diameter, most results are more or less comparable with our own for smaller tumors, except for the Mount Sinai series, which, although small in numbers of patients, is somewhat better (Table  2 ) (23). Results for larger tumors (Ն30 mm) are generally modest, although, in contrast to our own experience, a few successes were recorded. Reviewing the four series with a Ն30 mm category, 9.1% (3 of 33) of these large tumors retained hearing of class A or B. It is of interest to consider studies using the entire tumor diameter (including the IAC), because, in aggregate, they represent a sizable patient population (Table 3) . However, the different method of measurement precludes meaningful comparison.
Both surgeon and patient alike would always select a hearing-conservative approach, no matter how remote *New Hannover classification for tumor extension (11): T1, purely intrameatal; T2, intrameatal and extrameatal; T3a, filling the cerebellopontine cistern; T3b, reaching the brain stem; T4a, compressing the brain stem; T4b, severely dislocating the brain stem and compressing the fourth ventricle.
†New Hannover classification for hearing: H1, 0 to 30 dB and 100% to 70% SDS; H2, 31 to 50 dB and 69% to 50% SDS; H3, 51 to 90 dB and 49% to 5% SDS; H4, 91 to 120 dB and 4% to 1% SDS; H5, Ն120 dB and 0% SDS. (14) 15-19 (15) 40 (6) 60 (9) 20-24 (9) 11.1 (1) 88.9 (8) 25-29 (7) 14.3 (1) 85.7 (6) Ն30 (7) 28. (13) 15-19 (10) 70 (7) 30 (3) 20-24 (4) 25 (1) 75 (3) 25-29 (2) 50 (1) 50 (1) Ն30 (2) 50 (1) 50 (1) Fischer et al (16) 20-29 (39) 5 (2) 95 (37) Ն30 (30) 10 (3) 90 (27) 
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the chance of success, were there not some additional morbidity from having made the attempt. In this case, intelligent clinical decision making requires a quantitative assessment of associated morbidities such as facial function, balance, cerebrospinal fluid (CSF) leak, persistent headache, operating time, and tumor recurrence. Facial function is widely considered to be a most important criterion for success in AN surgery. An earlier analysis of size-matched tumors comparing the RS and TL approaches in our own series detected no difference in outcome (28) . These findings are supported by several other studies on this subject (26, 29, 30) . Although the ultimate results may be similar, preserving the auditory nerve occasionally makes the facial nerve dissection more tedious and time consuming. A clean proximal (at the brain stem exit) and distal (in the IAC) division of the entire eighth nerve helps to establish the facial nerve dissection plane and thus facilitates more rapid removal. During dissection from the region of greatest adherence, typically just outside of the porus acousticus, visualization of the facial nerve can be obscured by overlying splayed and sometimes adherent fibers of the eighth nerve. Thus, although choice of a hearing conservation RS approach may not alter facial nerve functional outcome, it may prolong surgery.
The RS approach requires a greater degree of cerebellar retraction than the TL approach. Although postoperative T2-weighted MRI images often show a greater degree of cerebellar encephalomalacia after a RS approach, we have not noted a particular tendency toward ataxia. Another factor on balance outcome is the effect of leaving residual vestibular nerve fibers in the course of a hearing conservation attempt. To maximize the possibility of hearing preservation, most surgeons leave intact fibers of the eighth nerve that are not involved by tumor. These vestibular nerve remnants may generate perverse impulses that hinder vestibular compensation. It is our anecdotal impression that patients undergoing hearing conservation attempts are at higher risk of suffering persistent vestibular symptoms, although our results have yet to be studied formally.
A recent retrospective study conducted in our department compared CSF leak rates among the different approaches used for AN surgery (31) . With 100 surgeries in each cohort, this study identified no statistically significant difference in CSF leakage rates between the RS (10%) and TL (13%) approaches. Equally, there was no difference in the requirement for surgical closure of the CSF leak (3% of RS and 4% of TL patients). The finding that there is no difference seen in CSF leaks between these approaches is supported by data published in a recent study by Brennan et al. (32) .
Prolonged postoperative headache is a recognized complication of AN surgery that may have significant morbidity for the patient (33) (34) (35) . A recent study by Levo et al. (36) demonstrated that the RS approach carried a 3.8-times higher risk than the TL approach for postoperative headache. A study performed in our department has also confirmed a substantially higher incidence of postoperative headache after RS surgery compared with the TL approach (unpublished data). Attempts have been made to reduce the rate of postoperative headache after the RS approach by performing craniotomy instead of craniectomy. Although this technique has been shown to produce significantly reduced postoperative headache rate, a study by Ruckenstein et al. (38) demonstrated that, despite the performance of a cranioplasty, patients undergoing RS craniotomies experience significantly more postoperative pain than those patients having undergone TL resections (37) (38) (39) .
The RS approach seems to have a higher rate of tumor recurrence that the TL. Although the TL method affords direct microsurgical exposure of the entire length of the IAC, when attempting hearing conservation via the RS approach, it is possible to visualize only approximately the medial two thirds of the canal (40) . Although the fundus could be visualized directly via the RS route, this necessitates removal of a portion of the inner ear and thus precludes hearing preservation. When the lateral one third of the IAC is involved with tumor, the surgeon may elect to blindly dissect the portion in the fundus using angled instruments that reach beneath the overhanging inner ear. In such cases, a small button of tumor can easily be left in the canal's distal recess. Because such a remnant has an intact blood supply, it has the potential to generate a recurrence. Indeed, this phenomenon of regrowth from residual tumor left in the fundus during a RS hearing conservation approach is well-known (41). The incidence of its occurrence, however, is not known. Endoscopic inspection of the fundus has been proposed as a means of reducing this risk (42) . Because of this heightened risk of recurrence, we consider tumor involvement of the lateral one third of the IAC to be a factor weighing against choice of the RS technique.
It is our hope that the outcome data provided in this study, together with those of others, will help surgeons and patients with larger ANs to select an approach to their tumor that maximizes the probability of favorable outcome. To some extent, it depends on the valuation the patient places on his or her residual hearing. To help determine this, we encourage patients to wear an earplug in the tumor ear for a few days, to assess how much difficulty this poses in day-to-day life. If it has little impact, then the RS hearing conservation approach is probably not worth attempting because of the potential greater morbidity. Because of the numerous outcome variables involved, as well as the vicissitudes of patient preference, it is not practical to adhere to a formuladriven decision tree. By way of illustration, we would encourage using the RS approach to attempt hearing preservation for a 20-mm tumor with normal hearing, minimal involvement of the proximal IAC, and no porus erosion and discourage its use for a 35-mm tumor with marginal class B hearing that deeply invades the fundus and widely erodes the porus. A special circumstance, worthy of mention, is a CPA tumor that is suspected of being other than an AN (e.g., meningioma). In such cases, hearing preservation is much more probable than
ACOUSTIC NEUROMA: HEARING PRESERVATION SURGERY
with eighth nerve tumors, and the RS approach is well justified.
Finally, we would like to make mention of the difficulty encountered in performing meaningful metaanalysis of the published literature in this field. The limitations posed by use of noncomparable data presentations highlight the need for investigators to use comparable minimal reporting standards (such as those adopted by the AAO-HNS) when conveying results after acoustic neuroma surgery. 
Risk-Benefit Analysis of Using the
INTRODUCTION
Surgeons who manage acoustic neuroma (AN) want to select an operative approach that optimizes both tumor control and functional outcome. Until relatively recently, the vast majority of AN surgery conducted around the world used either the retrosigmoid (RS) or translabyrinthine (TL) approach. Traditionally, the middle fossa (MF) approach has been reserved for small tumors confined to the internal auditory canal (IAC). Over the last two decades, two teams (one each in Germany and Japan) have advocated for the use of the MF technique for larger tumors possessing a substantial component in the cerebellopontine angle (CPA).
1,2 Over the last 5 years, the MF approach has undergone a marked resurgence as a result of its proven superiority over the RS approach in hearing conservation. 3, 4 The MF approach is currently used in between 30% and 50% of AN microsurgeries in certain major American centers. 5 The use of the MF approach in tumors of 10 to 20 mm in diameter within the CPA remains controversial, because few data exist concerning hearing preservation and facial nerve function for tumors in this larger size range. Because the facial nerve (FN) lies in a surgically less favorable orientation when viewed from above (MF) as opposed to from the lateral perspective (TL or RS), concern has been raised as to whether FN functional outcome is adversely affected. In an earlier study, we demonstrated that choice of the MF approach for hearing preservation for smaller tumors (Յ10 mm in diameter in the CPA) carries an increased risk of transient FN dysfunction, but that that long-term outcome was similar to that with the RS approach. 3 The intention of the present study is to ascertain whether the enhanced hearing preservation capability of the MF approach has an impact on long-term facial function in larger tumors (Ͼ10 mm).
Patient Population
The primary study population consisted of a retrospective chart review of 153 MF resections for AN. Because 3 patients with neurofibromatosis type 2 underwent staged, bilateral approaches, the primary study group included 150 individuals. There were 76 female and 74 male patients. All patients had a confirmed histopathologic di- Complying with the recommendations of the Committee on Hearing and Equilibrium of the American Academy of Otolaryngology-Head and Neck Surgery, tumor size was estimated on axial enhanced-T1 magnetic resonance images (MRI) by excluding the intracanalicular segment and measuring only the size of the CPA component. 6 Tumors completely confined to the IAC were reported as an intracanalicular (IC) tumor. For tumors extending out of the IAC, the largest linear diameter was measured in a direction either parallel or perpendicular to the petrous ridge. Tumors were stratified into three size categories: IC (64), 1-9 mm CPA (42), or 10 -18 mm CPA (47). Tumor resection was total in 93.4% (143 of 153) patients, near total in 5.2% (8 of 153), and subtotal in 1.3% (2 of 153) ( Table I) . Near-total resection refers to leaving only a miniscule part of the tumor surface no more than 2 mm thick and 5 mm in diameter. Subtotal resection refers to any remnant larger than this.
Auditory function was assigned classification (A, B, C, or D) through pure-tone average and speech discrimination scores (SDS) according to the guidelines described by the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). 6 Pure-tone threshold average (PTA) was reported as an average of the air-conduction thresholds at 0.5, 1, 2, and 3 kHz (4 kHz when the threshold at 3 kHz was not determined). SDSs were obtained at presentation levels of up to 40-dB sensation level. Measurable hearing preservation was described as a PTA Ͻ90 dB hearing loss with any SDS. Rate of the functional hearing preservation was described as the ratio of the postoperative AAO-HNS class B and better results to preoperative class B and better hearing.
FN function was graded according to the HouseBrackmann system as recommended by the AAO-HNS and reported as early (within 48 h) and late (1 y postoperatively) outcome. 7 The rate of good FN function was expressed as the percentage of grade II and better result. A secondary study population was created to serve as a matched comparison for the largest MF subset when assessing facial function. This consisted of a group of 40 patients (tumor size 10 -18 mm CPA) who had undergone TL resection by the same skull base team over the same time frame as the MF study population. The patients in this control group were age-and tumor size-matched to the MF study population by random selection (to minimize bias) from our acoustic neuroma database.
The surgical technique of MF craniotomy was modified from that classically described by House. 8 To enhance exposure, the bone anterior and posterior to the IAC was widely removed and a specialized MF retractor was used. 9 In 2 cases, the superior petrosal sinus was occluded and transected. Closure of the operative field in the IAC was performed with a locally harvested muscle graft for cases earlier than 1998 and an abdominal adipose graft thereafter. Cranial nerve monitoring, including electromyography, evoked electromyography, and auditory brainstem response testing, was used in all operations.
Statistical analysis of the data was performed using the SPSS program for Windows (release 7.5, 1996; SPSS, Inc., Chicago, IL). Statistical significance was set at P Ͻ.05. In evaluation of the hearing preservation and FN outcome following the MF approach, each tumor-size category was compared with each other in paired comparisons using Pearson's 2 test. FN outcome in 47 cases (tumor size 10 -18 mm) that had undergone the MF approach was compared with that of 40 cases (tumor sizematched) who had undergone the TL approach using the same statistical test. Results of the 15-to 18-mm tumor subset removed with the MF approach were reported separately without statistical analysis resulting in a small sample size. Patient ages and the length of the recovery time for FN function achieved were compared among the tumor-size categories using a two-tailed independentsamples t test. The correlation of tumor size with hearing result and FN outcome and the correlation of hearing outcome with FN function were analyzed with Pearson's bivariate correlation test.
RESULTS
Auditory Function
Anatomic integrity of the cochlear nerve was preserved in 90.8% (139 of 153) of cases. The rate of cochlear nerve integrity preservation was slightly better for IC tumors (93.8%) than it was for 1-to 9-mm (90.5%) and 10-to 18-mm (87.2%) tumors. There was no significant difference in preoperative PTA and SDS among the tumor-size categories (Table II) . There was a strong correlation observed between tumor size and postoperative PTA (R ϭ 0.226, P Ͻ.01). SDS was also inversely correlated with tumor size (R ϭ -0.197, P Ͻ.05).
The rate of postoperative functional hearing preservation (class A/B) was 53.3% overall (72 of 135 patients with A or B preoperatively). The 10-to 18-mm CPA group had significantly poorer rates of hearing than the two small tumor size groups (Table II) . No significant difference in hearing outcome was observed between the IC and small CPA component (1-9 mm) groups. Pre-and postoperative hearing levels are presented in greater detail, categorized according to tumor size and AAO-HNS hearing class, in Table III . A statistical analysis of these categorical data also demonstrated poorer hearing in the largest tumor size group (Table IV) . Hearing improvement sufficient to alter AAO-HNS class (from B to A) was observed in only 2 patients (one each IC and 1-9 mm). No ears with either class C or D hearing preoperatively achieved good hearing (A or B) postoperatively. Because our primary interest is with tumors Ͼ10 mm in CPA diameter, special mention will be made of the results in this group. Only 15 of 44 ears (34%) with preoperative A or B hearing maintained this level following tumor removal. This is only approximately one half of the success rate achieved with the IC (62.2%) and 1-to 9-mm (63.1%) groups. To screen for size effect within the 10-to 18-mm cohort, we separately considered the 11 patients with tumor diameter of 15 to 18 mm in the CPA. Preoperative hearing was class A 7 and B 4 of whom 36.4% (4 of 11) retained good hearing (A or B) postoperatively. This result is similar to that of the entire 10-to 18-mm group.
Facial Nerve Function
In the MF approach, the rate of anatomic FN preservation was 96% (147 of 153) overall: IC ϭ 96.9%, 1-9 mm ϭ 97.6%, and 10 -18 mm ϭ 93.6%. With the TL approach (tumors 10 -18 mm), the FN was preserved in all 40 cases (100%). The early and late FN outcome in all MF size categories as well as the comparison TL series appears in Table V 
Linkage Between Auditory Function and Facial Nerve Outcome
A linkage was observed between late FN function and hearing outcome (Table VII) . Patients with success at hearing preservation were more likely to have a favorable FN outcome. This relationship was present for all three size categories.
A Pearson's bivariate correlation analysis of the 153 MF patients showed a correlation between hearing and facial outcome (R ϭ 0.305, P Ͻ.01). The same correlation was found for tumors Յ10 mm in the CPA (including IC tumors; R ϭ 0.210, P Ͻ.05) and tumors 10 to 18 mm (R ϭ 0.306, P Ͻ.05).
DISCUSSION
Widespread use of magnetic resonance imaging has resulted in an increased detection of small-sized AN and an increased number of interventions for hearing preservation. As major centers have accumulated considerable experience in hearing conservation in recent years, success rates in preserving useful hearing have improved substantially. A well-established trend has been the increased use of the MF approach and its application in tumors with extracanalicular components in the CPA. The literature concerning outcomes for MF approaches in tumors larger than 10 mm in the CPA is limited. Many teams have been hesitant to adopt this method for larger tumors because of concerns regarding the unfavorable position of the facial nerve, limited access to the inferior aspect of the CPA, and the need for lengthy and more forceful retraction of the temporal lobe. Other teams, particularly those who have had favorable experiences with smaller tumors, have begun to explore using this method in larger lesions. It is generally accepted that the upper size limit for the MF approach is in the range of 16 to 20 mm in CPA component. The reason that the upper limit is not a fixed number is explained by the variable geometry of the CPA itself. As a general rule of thumb, we think it unwise to undertake MF approaches to AN when more than minor brainstem contact has occurred. In terms of osseous exposure, some authors have argued that a family of MF approaches are used to address AN with the "standard" approach for IC and an "enlarged" approach for tumors with a significant CPA component.
1,10 As we have done more MF cases, we have found that it is beneficial to make a fairly wide exposure of the IAC and adjacent posterior fossa dura regardless of the tumor size. In the TL approach, it is generally acknowledged that there is but one fundamental technique used for AN of all sizes. Admittedly, the opening is made somewhat wider for larger tumors, but this is a variation on the same theme. We think the same principle applies to the MF approach.
In the present study, the maximum diameter of the tumor resected using the MF approach was 18 mm. There were 11 cases with a tumor in the 15-to 18-mm range and 47 larger than 10 mm in the CPA. Our primary reason for undertaking this study was to determine the degree of success in hearing preservation for these larger tumors and to ascertain whether undertaking this effort carries a cost in terms of long-term FN outcome. There are three means of measuring "success" in hearing conservation surgery: integrity of the cochlear nerve, presence of any degree of measurable hearing, and maintenance of useful levels of hearing. Because we think the latter measure is by far the most valid indicator of success, our analysis will emphasize this measure. In the present study, of 135 MF patients with good preoperative hearing (class A/B) (includes tumors of all sizes), 53.3% maintained good hearing after tumor resection. When examined according to tumor size, larger tumors (10 -18-mm CPA) retained good hearing (A or B) approximately half as often (34%) as the IC (62.2%) and Ͻ9-mm CPA (63.1%). There is a paucity of data on hearing outcomes in the MF approach to tumors with substantial extracanalicular components. The earlier literature includes 156 patients (239 patients for evaluation of FN function) with a 10-to 20-mm CPA component from four studies. 4,10 -12 In these, the rate of good hearing (A or B) preservation was 33.3% (Table VIII) . These data are similar to our own. Only studies with sufficient detail could be tabulated in this manner. Much of the literature was not suitable for comparison as a result of inconsistent methods of reporting tumor size and hearing outcome. A number of studies reported overall tumor size, including the IAC component. This tends to overestimate the size of the tumor by as much as 10 mm, a huge factor when evaluating small tumor components within the CPA. In the future, we are hopeful that every study will include data in a standardized format, such as that recommended by the AAO-HNS, to facilitate meta-analyses. 6 It seems worthwhile to make mention of the points in operative technique which enhance the possibility of hear- 
Total (47) ing conservation. Several points are often mentioned by surgeons in the field with sufficient regularity to constitute conventional wisdom: work only medial to lateral to avoid traction of the fragile eighth nerve entering the modiolus, cut the vestibular nerves early, avoid using bipolar cautery, and work "underwater" using copious irrigation. 10, 13, 14 Even though our hearing results are at least comparable to the best reported in the literature, our practice is often at variance to these pearls of conventional wisdom. First of all, with the viewpoint provided by the MF approach, it is difficult to dissect medial to lateral during the entire tumor dissection. The key point is that traction on the cochlear fibers must be avoided to the greatest extent possible. This may require sharp dissection of the tumor-nerve interface. For the second point, we think hearing preservation is enhanced when every eighth nerve fiber not infiltrated by tumor is preserved. Leaving some vestibular fibers lends mechanical support to the cochlear nerve and helps to avoid injury to the tributaries of the internal auditory artery. A possible trade-off on this technique is a higher possibility of postoperative vestibular symptoms. Concerning potential deleterious effects of cautery, we regularly use the irrigating microbipolar at low power settings. This should be done judiciously, aimed precisely at the offending vessel, and not in the immediate vicinity of facial or auditory nerves. Meticulous hemostasis facilitates orderly microdissection. A final technical point is that hearing is often lost during dissection of tumor from the fundus of the IAC. Because of overhang of the transverse crest and FN, dissection of its deepest recesses must often be done blindly. 15, 16 Use of long angled instruments (e.g., curettes, hooks, and ball-hooks) is helpful.
For any size of AN, preservation of the FN is technically more challenging using the MF approach. Often the nerve is located on the superior surface of the tumor interposed between the tumor and the surgeon's point of view. Thus, the surgeon must work past the nerve, and it must be manipulated from side to side during tumor dissection. By contrast, in the RS and TL approaches, the FN can remain undisturbed in its deflected course and thus sustains a lesser degree of trauma. In an earlier study, we found that although transient FN dysfunction was substantially higher in small tumors (Ͻ10 mm CPA), longterm outcome was the same as with other approaches. 17 In the present study, it has become clear that with larger tumors (10 -18-mm CPA) the MF approach carries a significantly higher risk of long-term residual FN dysfunction, the most informative comparison in the 10-to 18-mm CPA size group between the MF and TL approaches. With the MF, good long-term FN function (grade I/II) was achieved in only 80.9% (38 of 47) of cases, whereas in TL 100% (40 of 40) achieved this result. This difference was statistically significant (P ϭ .003). A potential source of bias should be noted in these data. Less-than-complete tumor resection was performed in 8.6% of MF cases and 17.5% of TL. This more conservative resection could have boosted the FN outcome in the TL group. Two earlier studies on the MF approach contain long-term FN outcome data in the size range of interest. In these, good FN function (1 or 2) was achieved in 85.2% (167 of 196). 4, 10 It is interesting that a concurrence was found between good FN function and functional hearing outcome (Table VII) . The linkage between either good or bad outcome for both functions probably relates to the biologic properties of the tumor such as the tendency to have an adhesive tumornerve interface.
The results of this risk-benefit analysis are useful in advising AN patients with good hearing and a sizable CPA component. For patients with tumors Ͻ10 mm in diameter, the MF approach is clearly superior because it has an equivalent long-term FN result (compared with RS and TL approaches) and allows for a Ͼ60% retention of good hearing. For patients with good hearing and a tumor in the 10-to 18-mm CPA range, the deliberation is more 17 Recently, we have observed that the RS approach is only approximately half as successful in preserving hearing for tumors in this size range. 18 With its superior FN results compared with the MF approach, this may seem a reasonable alternative. However, the RS approach does not permit adequate access of the fundus of the IAC without removing a portion of the vestibule and common crus, a maneuver incompatible with hearing preservation. 19 The RS approach is also associated with a significantly higher incidence of persistent postoperative headache. 20 For these reasons, when tumor extends deep into the fundus of the IAC, we tend to avoid the RS approach.
The results of this study have altered our recommendations to patients. Formerly, we recommended the MF approach for all tumors with good hearing up to 18 mm diameter in the CPA. Our current practice is to inform patients with 10-to 18-mm CPA components that while the MF approach is clearly superior for hearing, it carries with it a somewhat higher incidence of persistent facial paresis and synkinesis. We explain the probabilities involved and allow the patient to judge the relative importance of hearing and facial function. The surgeon should not assume that patients would automatically choose a lowered risk of facial neuropathy over a possibility of saving hearing. In an earlier study of patient-perceived outcomes following AN surgery, we were surprised to note that many patients with both facial dysfunction and unilateral deafness actually rated the auditory deficit as more life disturbing. 21 It should be noted that certain other factors (not quantified in the present study as a result of incompleteness of the available data) are also considered in risk stratification. For example, we suspect that extensive osseous erosion of the porus acusticus and deep penetration of the fundus are adverse predictors of success in hearing preservation. The limited hard data available and complexity of the variables involved makes it difficult to codify such factors into an explicit set of rules. To illustrate how these factors come into play in our advice to patients, we would be more enthusiastic in our recommendation for a hearing conservation approach in a 12-mm CPA tumor with normal hearing, an empty fundus, and a narrow porus than we would be in an 18-mm CPA tumor with marginal class B hearing, deep fundus involvement, and a widely eroded porus acousticus.
Because of the technical challenges faced in obtaining adequate exposure and conducting an effective dissection, we recommend that microsurgical teams not undertake the MF approach to tumors with sizable CPA components until they have become facile with smaller lesions.
CONCLUSION
When considering surgical options, patients with Ͼ10-mm tumors should be advised that choosing the MF approach for hearing preservation carries a somewhat higher risk of persistent FN dysfunction than the TL approach. 
